PLK1:0.87 nM (IC50)
PLK2:5 nM (IC50)
PLK3:56 nM (IC50)
[1]. Xie FF, et al. Volasertib suppresses tumor growth and potentiates the activity of cisplatin in cervical cancer. Am J Cancer Res. 2015 Nov 15;5(12):3548-59.
[2]. Abbou S, et al. Polo-like Kinase Inhibitor Volasertib Exhibits Antitumor Activity and Synergy with Vincristine in Pediatric Malignancies. Anticancer Res. 2016 Feb;36(2):599-609.
[3]. Rudolph D, et al. BI 6727, a Polo-like kinase inhibitor with improved pharmacokinetic profile and broad antitumor activity.Clin Cancer Res. 2009 May 1;15(9):3094-102. Epub
陕西缔都新材料有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
缔都医药